OUR PRODUCTS

MOBILE APPS

GENERAL INFO

PLX

Stock ticker: ASE

PRICE

CHANGE

CAPITALIZATION

Protalix BioTherapeutics (PLX) Earnings Date & Reports

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx... Show more

Industry: #Servicestothe Health Industry

Get AI intraday signals

A.I. Advisor

published Earnings

PLX is expected to report earnings to fall 275.00% to 7 cents per share on November 17

Protalix BioTherapeutics PLX Stock Earnings Reports

Q3'25

Est.

$0.07

Q2'25

Missed

by $0.15

Q1'25

Missed

by $0.08

Q4'24

Est.

$0.10

Q3'24

Missed

by $0.03

The last earnings report on August 14 showed earnings per share of -3 cents, missing the estimate of 10 cents. With 702.06K shares outstanding, the current market capitalization sits at 117.82M.

View a ticker or compare two or three

Compare

PLX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PLX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PLX showed earnings on August 14, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of recombinant therapeutic proteins

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Servicestothe Health Industry

Address

2 University Plaza

Phone

+1 201 696-9345

Employees

208

Web

https://www.protalix.com